SavedAdd your journal

Journals / The European Research Journal / 2019 / Cilt: 5 - Sayı: 2

Are nasal steroids effective in children with adenoid hypertrophy?

Fevzi SOLMAZ
Mustafa Erhan AŞCIOĞLU
Osman DURGUT
Oğuzhan DİKİCİ
Mehmet HAKSEVER
Davut AKDUMAN
Pages
311–318
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: We believe that the use of intranasal steroids (mometasone furoate) for 6 weeks in patients with pediatric chronic nasal obstruction due to adenoid hypertrophy may be an effective treatment modality in alleviating symptoms and decreasing adenoid volume without causing systemic side effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Chronic nasal obstruction is a common disease of childhood.
📊
Key Findings & Data:The topical use of the aerosolized forms of corticosteroids therefore seems the most appropriate route to decrease systemic side effects.
💡
Conclusion & Impact:Conclusions: We believe that the use of intranasal steroids (mometasone furoate) for 6 weeks in patients with pediatric chronic nasal obstruction due to adenoid hypertrophy may be an effective treatment modality in alleviating symptoms and decreasing adenoid volume without causing systemic side effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Nasal steroids · adenoid hypertrophy · flexible endoscopy

Abstract

Objectives: Chronic nasal obstruction is a common disease of childhood. Adenotonsillar hypertrophy plays an important role in obstructive sleep apnea. The topical use of the aerosolized forms of corticosteroids therefore seems the most appropriate route to decrease systemic side effects. The aim of our study is to demonstrate the effect of topical mometasone furoate especially on the adenoid volume in patients without any allergic story. Methods: The study group consisting of 30 males and 25 females was administered topical nasal mometasone furoate steroid treatment. The 20 patients were in the control group where saline solution (0.9% NaCl) treatment was administered consisted of 12 males and 8 females. Nasopharyngeal X-rays before treatment revealed that 25 patients were Grade 2 and 30 patients were Grade 3 according to the Fujioka method. Results: Flexible endoscopy performed before the treatment revealed that 20 patients were Grade 2, 11 patients were Grade 3 and 24 patients were Grade 4. Nasal endoscopies performed after 6 weeks of intranasal topical steroid therapy revealed that 45 patients were Grade 1 and 10 patients were Grade 2. A statistically significant difference was present between endoscopic grades before and after treatment (p < 0.0001). Nasal endoscopies performed after 6 weeks in control group receiving saline solution treatment revealed Grade 2 in 7 patients, Grade 3 in 10 patients and Grade 4 in 3 patients. There was no statistically significant difference between in the prior and later grades of the control group (p = 0.3125). Conclusions: We believe that the use of intranasal steroids (mometasone furoate) for 6 weeks in patients with pediatric chronic nasal obstruction due to adenoid hypertrophy may be an effective treatment modality in alleviating symptoms and decreasing adenoid volume without causing systemic side effects.

🔖

Cite This Article

SOLMAZ, F., AŞCIOĞLU, M. E., DURGUT, O., DİKİCİ, O., HAKSEVER, M., AKDUMAN, D. (2019). Are nasal steroids effective in children with adenoid hypertrophy?. The European Research Journal, Cilt: 5 - Sayı: 2, 311–318. https://ajindex.com/articles/361042

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lumeng JC, Chervin RD. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc 2008;5:242-52
  2. O’Brien LM, Holbrook CR, Mervis CB. Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder. Pediatrics 2003;111:554-63
  3. Blunden S, Lushington K, Lorenzen B, Wong J, Balendran R, Kennedy D. Symptoms of sleep breathing disorders in children are underreported by parents at general practice visits. Sleep Breath 2003;7:167-76
  4. Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics 2008;122;e149-55
  5. Marcus CL. Sleep-disordered breathing in children. Am J Respir Crit Care Med 2001;164:16-30
  6. Raphael G, Kaliner M. The tonsils and adenoids: Allergy and the pharyngeal lymphoid tissue. In Otolaryngologic Clinics of North America. Edited by Kornblut AD, Saunders WB: Philadelphia, 1987:pp. 295-303
  7. Capdevila OS, Kheirandish-Gozal L, Dayyat E, Gozal D. Pediatric obstructive sleep apnea: complications, management, and long-term outcomes. Proc Am Thorac Soc 2008;5:274-82
  8. Cowan DL, Hibbert J. Tonsils and adenoids: In Scott Browns Pediatric Otolaryngology (Vol. 6) 6th edition. Edited by Kerr AG, Adams DA, Cinnamond MJ. Butterworth Heinemann, Oxford Chpt 1997;18, p.4-8
  9. Li AM, Wong E, Kew J, Hui S, Fok TF. Use of tonsil size in the evaluation of obstructive sleep apnoea. Arch Dis Child 2002;87:156-9
  10. Schechter MS. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Pediatrics 2002;109: e69
  11. American Academy of Pediatrics. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109:704-12
  12. Brodsky L. Modern assessment of tonsil and adenoids. Pediatr Clin North Am 1989;36:1551-69
  13. Tracy JM, Demain JG, Hoffman KM, Goetz DW. Intranasal beclomethasone as an adjuvant to treatment of chronic middle ear effusion. Ann Allergy Asthma Immunol 1998;80:198-206
  14. Brannan MD, Herron JM, Affrime MB. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther 1997;19:1330-9
  15. Kheirandish-Gozal L, Serpero LD, Dayyat E, Kim J, Goldman JL, Snow A. Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep a